Guava Leaf Extract Suppresses Fructose Mediated Non-Alcoholic Fatty Liver Disease in Growing Rats
Prateek Sharma,Jayachandran Nair,Anurag Sinh,Thirumurthy Velpandian,Ruchi Tripathi,Rajani Mathur,- Shivangi
DOI: https://doi.org/10.2147/DMSO.S381102
2022-09-16
Abstract:Prateek Sharma, 1 Jayachandran Nair, 1 Anurag Sinh, 1 Shivangi, 1 Thirumurthy Velpandian, 2 Ruchi Tripathi, 1 Rajani Mathur 1 1 Department of Pharmacology, Delhi Institute of Pharmaceutical Science and Research, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India; 2 Department of Ocular Pharmacology, Dr. R.P. Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India Correspondence: Rajani Mathur, Department of Pharmacology, Delhi Institute of Pharmaceutical Science and Research, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, Sec III, New Delhi, 110017, India, Tel +91-011-29551490, Fax +91-011-29554503, Email Purpose: Fructose is highly lipogenic, and its unhindered ingestion by children and adolescents is understood to induce hypertriglyceridemia and non-alcoholic fatty liver disease (ped-NAFLD) that is till date managed symptomatically or surgically. The aim of the present study was to investigate the potential of hydroethanolic extract of leaves of Guava (PG-HM) to suppress the alterations in the hepatic molecular signals due to unrestricted fructose (15%) drinking by growing rats. Methods: Weaned rats (4 weeks old) in control groups had ad libitum access to fructose drinking solution (15%) for four (4FDR) or eight (8FDR) weeks, ie, till puberty or early adulthood, respectively, while treatment groups (4PGR, 8PGR) additionally received PG-HM (500 mg/kg, po). Results: The PG-HM suppressed ped-NAFLD through hepatic signalling pathways of 1) leptin-insulin (Akt/FOX-O1/SREBP-1c), 2) hypoxia-inflammation (HIF-1ɑ/VEGF, TNF-ɑ), 3) mitochondrial function (complexes I–V), 4) oxidative stress (MDA, GSH, SOD) and 5) glycolysis/gluconeogenesis/ de novo lipogenesis (hexokinase, phosphofructokinase, ketohexokinase, aldehyde dehydrogenase). Parri passu , the insulin sensitizing effect of PG-HM and its ethyl acetate fraction (PG-EA) was elucidated using HepG2 cells grown in media enhanced with fructose. Further, in murine hepatocytes cultured in fructose-rich media, PG-HM (35 μg mL-1) outperformed Pioglitazone (15 μM) and Metformin (5 mM), to suppress hepatic insulin resistance. Conclusion: This study established that hydroethanolic extract of leaves of Guava (PG-HM) has potential to suppress hepatic metabolic alteration for the management of the pediatric NAFLD. Graphical Keywords: Psidium guajava , pediatric NAFLD, insulin sensitizer, mitochondrial function Graphical Today, there is increasing interest in the use of traditional medicines (TMs) as they are perceived to be safe, economical, accessible and effective. The chemical diversity of TMs has been successfully tapped as novel leads or dietary supplements for prevention and treatment of human diseases. Globally, the various parts of the Guava plant ( Psidium guajava Linn., fam Myrtaceae) have been extensively used as TM and many of these traditional practices have been evaluated and provided with pharmacological and phytochemical basis. 1 The organic and aqueous extracts of guava leaves have been tested and found to possess antibacterial, antifungal, antidiarrhoeal, antiplasmodial, anti-cough, antiinflammatory, antipyretic, analgesic, immunomodulatory, spasmolytic, ulcer protective, nephroprotective, hepatoprotective and hypoglycemic properties. 1 Comprehensive studies have established that the oral administration of the aqueous and ethanolic extracts of guava leaves to Albino rats is safe upto the doses of 100–500 and >2000 mg/kg, respectively, with no signs of toxicity or mortality. 2,3 In clinical trials, the guava leaves have been associated with curative effects for infantile rotavirus enteritis, hypertension, abdominal pain, acute diarrhea, dysmenorrhea and diabetes. The formulation of aqueous guava leaf extract is approved as Food for Specified Health Uses and commercially available. The main chemical components of leaves are flavonoids, essential oil, triterpenoids, tannins, flavonoids and saponins. The mature leaves have high concentrations of phenolic flavonoids like quercetin (2883.08 mg kg −1 ), myricetin (208.44 mg kg −1 ), luteolin (51.22 mg kg −1 ) and kaempferol (97.25 mg kg −1 ). 4 It is well established that the quercetin (Qu) is one of the major phytoconstituents in the leaves of Guava and can be attributed for its medicinal effects. 5,6 As part of the modern-day lifestyle, today's children and adolescents are rampantly consuming fructose in the form of high fructose corn syrup that is a constituent of sweetened beve -Abstract Truncated-
endocrinology & metabolism